Delta Wealth Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$374K Hold
1,487
0.27% 35
2026
Q1
$323K Sell
1,487
-100
-6% -$22.2K 0.25% 40
2025
Q4
$363K Hold
1,587
0.3% 39
2025
Q3
$367K Hold
1,587
0.29% 36
2025
Q2
$295K Sell
1,587
-101
-6% -$18.8K 0.25% 38
2025
Q1
$354K Hold
1,688
0.32% 28
2024
Q4
$300K Buy
1,688
+87
+5% +$16K 0.28% 36
2024
Q3
$316K Hold
1,601
0.3% 33
2024
Q2
$275K Hold
1,601
0.27% 39
2024
Q1
$292K Buy
+1,601
New +$276K 0.3% 41

Other funds holding ABBV

Delta Wealth Advisors's ABBV Position: Q2 2026 in Review

Delta Wealth Advisors held its AbbVie (ABBV) position steady in Q2 2026 at 1,487 shares worth $374K. The position accounts for 0.27% of the portfolio, ranked #35.

Delta Wealth Advisors first reported a position in ABBV in Q1 2024 and has held it in 10 quarters since. 1,587 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Delta Wealth Advisors held 1,487 shares of AbbVie worth $374K as of Q2 2026.
  • Delta Wealth Advisors left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.27% of Delta Wealth Advisors's portfolio in Q2 2026, its #35 holding.
  • Delta Wealth Advisors first reported a position in AbbVie in Q1 2024 and has held it in 10 quarters since.
  • 1,587 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Delta Wealth Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.